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loop may result from deficiencies in cardiomyocyte shape, size or
differentiation. We provide an update on ongoing work to determine
the earliest developmental timepoints at which tbx5 is necessary for
normal cardiac function, as well as the functional relevancy of graded
tbx5 expression, by using the Tg(hsp70:tbx5-GFP) and Tg(cmlc2:tbx5-
GFP) lines of zebrafish.
doi:10.1016/j.ydbio.2009.05.403
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Developing organs are assembled from multiple populations of
progenitor cells that originate from distinct locations at different
developmental stages. During heart development, the initial heart
tube forms from cardiomyocytes arising from a portion of the anterior
lateral plate mesoderm referred to as the first heart field (FHF). Prior
studies in amniotes have shown that new cardiomyocytes originating
froma second heart field (SHF) are later added to the poles of the heart
tube. Many congenital heart diseases affect portions of the heart
derived from the SHF; however, we still do not understand the
mechanisms that regulate the specification, migration, and differen-
tiation of SHF cells. Recent studies from our laboratory have provided
the first evidence that there are two phases of cardiomyocyte differen-
tiation in zebrafish, strongly suggesting the existence of a zebrafish
SHF. Treatment of zebrafish embryoswith SU5402 inhibitor from 24 to
48hpf, covering the window when cells are added to the arterial pole,
significantly reduces the number of cells added to the arterial pole.
Thus, after differentiation of the FHF is complete, FGF signaling is still
important for the addition of new cardiomyocytes from the SHF.
Continuous observation of a transgenic reporter of FGF signaling
indicates FGF-responsive cells scattered in a region adjacent to the
arterial pole, followed by congregation of FGF-responsive cells at the
arterial pole. These findings, together with the expression of fgf8 in the
ventricle, suggest a model in which Fgf8 functions as an attractive cue
regulating the migration of new cardiomyocytes to the arterial pole.
doi:10.1016/j.ydbio.2009.05.404
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Heart development requires contributions from, and interactions
between, discrete cell populations including primary and secondary
heart fields (SHF), cardiac neural crest (CNC), and the proepicardial
organ (PEO). Birth defects caused by abnormal CNC and SHF
development include DiGeorge and CHARGE syndromes. Aspects of
these syndromes are phenocopied in fibroblast growth factor (Fgf)8 or
Fgf15 null mutant mice. Fgf3 and Fgf10 are expressed in sites relevant
to early heart development, but single null mutants do not have heart
defects. Fgf3−/−;Fgf10−/− double mutants, however, die at E11.011.5.
They lack NC-derived proximal 9th cranial ganglia, exhibit pericardial
edema, hypoplastic ventricles and outflow tract cushions, and lack 4th
pharyngeal arch arteries, showing that Fgf3 and Fgf10 are required
redundantly for normal CNC and cardiovascular development. To test
the hypothesis that Fgf3 and Fgf10 are required for correct migration
and/or survival of CNC, and for development or morphogenesis of the
heart, we assessed expression of NC and cardiac markers. We find that
specification and earlymigration of NC are normal, but NCmigration is
reduced by E9.510.5. Expression of Nkx2.5 and Islet1 is markedly
reduced in the double mutant; whereas Fgf8 and Fgf15 are unaffected.
In contrast to the exclusively anterior pole defects of Fgf8 or Fgf15
mutants, Fgf3−/−;Fgf10−/− embryos also showposterior pole defects,
including reduced investment of epicardial cells from the PEO. Studies
are underway to define the expression sites of Fgf3 and Fgf10 required
for normal CNC and cardiovascular development.
doi:10.1016/j.ydbio.2009.05.405
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Development of the right ventricle and outflow tract of the
mammalian heart involves cell populations within the primary heart
tube, as well as extracardiac contributions, as cells from outside the
primary heart tube progressively add to it. Proper morphogenesis of
these tissues is critical for cardiac function. The anterior heart field
(AHF) is a secondary cell lineage of the myocardium that contributes
substantially to the outflow tract and right ventricle. Here we present
evidence that extracardiac BMP signaling is essential for the addition of
progenitor cells to the heart. Several tissue-specific genetic ablations
and explant culture experiments demonstrate a direct requirement for
BMP signaling in regulating myocardial differentiation and prolifera-
tion in the AHF. Embryos lacking BMP receptor 1A (BMPR1A) in the
AHF invariably display severely hypomorphic outflow tract and right
ventricle structures. In contrast, Bmpr1a in the primary heart tube is
dispensable for development of these tissues, but is necessary for later
cardiac gene expression and cardiomyocyte proliferation. We further
find that BMP antagonism by Noggin is necessary to keep myocardial
proliferation in check. Surprisingly, although BMPR1A signal transduc-
tion requires the canonical signal transducer Smad4 in the primary
heart tube, BMPR1A signaling in the developing AHF is independent of
Smad4. Thus, BMP signaling and its antagonism balance myocardial
proliferation in the ventricles. Earlier, BMP signaling acts via a Smad4-
independent pathway to regulate addition of myocardial progenitors
to the outflow tract and right ventricle.
doi:10.1016/j.ydbio.2009.05.406
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In a forward genetic screen in mice we identified a novel mutant
line with a multitude of severe abnormalities and fetal lethality. We
named this line manta ray (mray) in reference to its craniofacial
abnormalities, which include orofacial clefting. In addition to
craniofacial defects, homozygous mutants are defective in brain,
heart, skin and vascular development. The brain defects in particular,
include a smaller sized forebrain partly resulting from cortical
thinning. The craniofacial phenotype points to an abnormal neural
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